Physician profile
Edwin Pan
NPI 1467463851
$7,977.93
in general payments reported to CMS, 2019-2025
21 companies · $989 in 2025
The $989 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $680 · 2021: $1,906 · 2022: $1,561 · 2023: $1,448 · 2024: $927 · 2025: $989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,363.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,083.27 | 2020-2024 | |
| Agile Therapeutics, INC. | $1,168.77 | 2021-2024 | Twirla |
| Avion Pharmaceuticals | $1,150.95 | 2019-2023 | Balcoltra |
| Sumitomo Pharma America, INC. | $1,046.08 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $451.42 | 2022-2024 | |
| Lupin INC. | $373.42 | 2019-2020 | |
| Astellas Pharma US INC | $305.07 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $266.75 | 2024-2025 | Cologuard Collection Kit |
| Myovant Sciences INC. | $239.00 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $221.72 | 2023-2025 | |
| Therapeuticsmd, INC. | $148.12 | 2019-2022 | |
| Exeltis, USA INC. | $111.48 | 2025 | Slynd |
| Evofem Biosciences, INC. | $86.35 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $58.14 | 2019-2021 | |
| Biogen, INC. | $57.93 | 2025 | Zurzuvae |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $50.77 | 2023-2024 | Accrufer |
| Scynexis, INC. | $49.59 | 2022 | |
| Hologic Sales and Service, LLC | $38.21 | 2021-2025 | Aptima |
| Myriad Women'S Health, INC. | $26.12 | 2023 | Myrisk |
| Viiv Healthcare Company | $25.28 | 2025 | Apretude |
| Biohaven Pharmaceuticals, INC. | $19.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.